Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$1.76 - $2.83 $10,384 - $16,697
5,900 Added 35.24%
22,641 $57,000
Q3 2023

Nov 06, 2023

BUY
$1.99 - $2.45 $553 - $681
278 Added 1.69%
16,741 $40,000
Q2 2023

Jul 27, 2023

BUY
$2.1 - $3.36 $2,803 - $4,485
1,335 Added 8.82%
16,463 $38,000
Q1 2023

May 02, 2023

BUY
$2.13 - $3.6 $943 - $1,594
443 Added 3.02%
15,128 $38,000
Q4 2022

Feb 09, 2023

BUY
$2.05 - $3.47 $3,628 - $6,141
1,770 Added 13.7%
14,685 $36,000
Q3 2022

Nov 02, 2022

SELL
$0.63 - $5.47 $6,222 - $54,027
-9,877 Reduced 43.34%
12,915 $37,000
Q2 2022

Aug 01, 2022

SELL
$4.27 - $8.26 $59 - $115
-14 Reduced 0.06%
22,792 $103,000
Q1 2022

May 04, 2022

SELL
$7.07 - $11.62 $4,595 - $7,552
-650 Reduced 2.77%
22,806 $144,000
Q4 2021

Feb 07, 2022

BUY
$10.49 - $14.28 $246,053 - $334,951
23,456 New
23,456 $273,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.